Health

Myocarditis Biomarker Found; Siblings and CVD; BP Wonders in Giraffes

Circulating microRNA represents a way to separate patients with acute myocarditis from those with myocardial infarction. (New England Journal of Medicine)

CDC continues to investigate reports of myocarditis and pericarditis following mRNA COVID-19 vaccines. Vaccination is still recommended for everyone ages 12 and up.

The tobacco epidemic must be stopped, said the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology. (Circulation)

EMS call data from the Boston area support the idea that patients were reluctant to call emergency services for cardiac-related care during the first COVID-19 wave. (Health Affairs)

Who were most at risk for a heart attack during the pandemic? People with familial hypercholesterolemia and established atherosclerotic cardiovascular disease who were diagnosed with COVID-19. (American Journal of Preventive Cardiology)

A weight loss program consisting of low-calorie soups and shakes may have the added benefit of reducing blood pressure (BP), according to a post-hoc analysis of the DiRECT trial. (Diabetologia)

Elderly patients undergoing revascularization for complex coronary artery disease fared similarly in the long term after percutaneous coronary intervention (PCI) and bypass surgery. (Journal of the American College of Cardiology)

The white matter damage in cerebral small vessel disease was not helped by intensive BP lowering, the small PRESERVE trial showed. (Stroke)

People with one or two siblings may enjoy better heart health than peers without siblings, Swedish registry data suggested. Any more than that, however, and cardiovascular risk increased. (BMJ Open)

Serum soluble osteoclast-associated receptor levels may have prognostic value in acute coronary syndrome, one hospital found. (Scientific Reports)

Patients with morbid obesity did not have inherently worse outcomes after transcatheter aortic valve replacement (TAVR), but the ratio of visceral adipose tissue to subcutaneous adipose tissue was a predictor of 2-year mortality. (Journal of the American Heart Association)

Smartwatch ECG monitoring caught three-quarters of arrhythmic complications after TAVR during the pandemic, a Chinese center reported in a preprint paper. (medRxiv)

European consensus is that cardiac troponin testing should be performed before and after PCI in patients with chronic coronary syndrome, with a cutoff of >5 times the 99th percentile upper reference limit flagging both type 4a myocardial infarction and major periprocedural myocardial injury in the absence of ECG or imaging evidence. (European Heart Journal)

FDA handed 510(k) clearance to iRhythm Technologies’ updated artificial intelligence-based algorithm for ECG monitoring and its redesigned Zio heart monitor. (Cardiovascular Business)

The One Drop app received the CE Mark for a BP management tool that provides in-app messages on BP trends, behavioral cues, and alerts for hypertensive crises.

A new ambulatory BP monitoring device — featuring a disposable chest-monitoring design — was released by Biobeat, the company announced.

Pediatrics reported on the case of a teenage girl with COVID-19 who developed coronary thrombosis-induced ST-segment elevation MI.

The mechanisms of Dengue virus infection-related cardiac dysfunction may be tied to inflammation, oxidative stress, and electrophysiological changes in the heart. (Heart)

Behold the giraffe, an animal that can withstand high BP thanks to various genetic and physiological features. (Ars Technica)

  • Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine. Follow

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.